07.10.2013
- German healthcare company Merck expects to get a long-term boost from study results in June that showed its main cancer drug Erbitux has an edge over rival product Avastin. Erbitux...
14.08.2012
- German drugmaker Merck KGaA beat forecasts for quarterly adjusted earnings and predicted faster growth in underlying core profit this year on higher pharmaceutical sales and a...
